
OLD Category: Oncology
February 7, 2019 / Transl Res.
Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients
February 7, 2019 / Haematologica
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
February 7, 2019 / Cell
Widespread and Functional RNA Circularization in Localized Prostate Cancer
February 7, 2019 / Ann Oncol.
The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial
February 6, 2019 / J Immunother Cancer
Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
February 6, 2019 / Gastroenterology
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
February 6, 2019 / Oncoimmunology.
Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape
February 5, 2019 / Int J Cancer.
Molecular alterations and poziotinib efficacy, a pan‐HER inhibitor, in human epidermal growth factor receptor 2 (HER2)‐positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2‐positive breast cancer patients
February 4, 2019 / Nat Commun.
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
February 4, 2019 / Visc Med
Immunologic Biomarkers and Biomarkers for Immunotherapies in Gastrointestinal Cancer
February 2, 2019 / Gut